Managing patients’ safety: Need for PharmacoVigilance Dr. Hanmant Barkate, MBBS, MD Associate Vice-President - Pharmaceuticals policy - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-05-26 07:21:00 Medical research Pharmaceuticals policy Health care Health Clinical research Clinical pharmacology Clinical trials Drug safety Pharmacovigilance Adverse drug reaction Nonsteroidal anti-inflammatory drug Yellow Card Scheme		Managing patients’ safety: Need for PharmacoVigilance Dr. Hanmant Barkate, MBBS, MD Associate Vice-President& Head Medical, Clinical & Regulatory affairs Intas Pharmaceuticals Ltd., Ahmedabad Add to Reading List Source URL: www.iimahd.ernet.in Download Document from Source Website File Size: 551,68 KB Share Document on Facebook

	Reference material Standard Workflow for the Revision of Drug Product Package Inserts (Adverse Drug Reaction Reports, etc.) DocID: 1rsP1 - View Document
	Managing patients’ safety: Need for PharmacoVigilance Dr. Hanmant Barkate, MBBS, MD Associate Vice-President& Head Medical, Clinical & Regulatory affairs Intas Pharmaceuticals Ltd., Ahmedabad DocID: 1rcEG - View Document
	PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015 Post marketing Control Division, DocID: 1p9e5 - View Document
	REVIEW ARTICLE A New, Evidence-based Estimate of Patient Harms Associated with Hospital Care John T. James, PhD DocID: 1p3Uj - View Document
	Pharmacovigilance: Monitoring the Safety & Efficacy of Animal Medicines Summary This document DocID: 1oBM7 - View Document